Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis.
Apfel Christian C, Zhang Kun, George Elizabeth, +8 more·Clinical therapeutics
BACKGROUND: Transdermal scopolamine (TDS) is a potential long-acting prophylactic antiemetic initially developed to prevent motion sickness. TDS is a centrally acting anticholinergic agent that was approved in 2001 by the US Food and Drug Administration for the prevention of postoperative nausea and vomiting (PONV). Al…